What is W.R. Berkley Corporation's earnings per share (EPS)?

W.R. Berkley Corporation (WRB) reported diluted earnings per share of $4.45 for fiscal year 2025. This represents a 2.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

W.R. Berkley Corporation (WRB) Financials

WRB

Trailing 12 months to June 30, 2026

Revenue $14.9B +4.3% YoY

Net Income $1.9B +9.5% YoY

EPS (Diluted) $4.87 +10.9% YoY

Operating Cash Flow $3.6B +3.0% YoY

Market Cap $25.6B as of Oct 3, 2026

Price / Sales 1.7x on $14.9B revenue, trailing 12 months to June 30, 2026

Price / Earnings 13.3x on $1.9B net income, trailing 12 months to June 30, 2026

Price / Book 2.6x on $9.8B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 31, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 31, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the WRB SEC filings page.

W.R. Berkley Corporation (WRB) reported $14.9B in revenue over the twelve months to Jun 30, 2026, up 4.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI WRB FY2025 2026-10-03

W. R. Berkley is an asset-heavy insurer whose cash generation remains strong, while 2025 growth produced less profit per dollar.

Operating cash flow exceeded net income in every reported year, reaching $3.6B against $1.8B of net income in FY2025. That persistent gap suggests operating balance-sheet movements materially support cash generation, rather than reported earnings alone explaining the cash outcome.

By FY2025, assets had reached $43.9B against $34.2B of liabilities, leaving a larger equity base to absorb the balance sheet. Debt-to-equity fell to 3.5x from 3.8x in FY2024, indicating modest deleveraging even as the business expanded.

Revenue grew 7.8% in FY2025 while net margin fell to 12.1% from its prior-year level, showing that additional volume did not fully translate into profit. Return on assets also eased to 4.1% from 4.3%, reinforcing that recent asset growth has not yet improved earnings efficiency.

Financial Health Signals

Financial Health Score 52/100

Scored as: Insurers peer group

Scored against insurers for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of W.R. Berkley Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Loss Ratio

Loss Ratio measures the claims an insurer paid out against the premiums it earned, so a lower ratio leaves more of every premium dollar with the company. W.R. Berkley Corporation scores 56/100 on it among other insurers.

Premium Growth

W.R. Berkley Corporation reported revenue of $14.7B in fiscal year 2025, against $13.6B in fiscal year 2024. Premium Growth ranks insurers on the three-year path of the premiums they write rather than on total revenue, and W.R. Berkley Corporation scores 52/100 among other insurers.

Capital

W.R. Berkley Corporation funded 22.1% of its assets with shareholders' equity at the end of fiscal year 2025, holding $9.7B of equity against $43.9B of assets. Capital ranks insurers on that cushion, and W.R. Berkley Corporation scores 41/100 among other insurers.

Investment Yield

Not available for W.R. Berkley Corporation, and counted as zero in the overall score.

Combined Ratio

Combined Ratio puts claims and running costs together against premiums earned, and a figure under 100% means the underwriting made money before any investment income was counted. W.R. Berkley Corporation scores 73/100 on it among other insurers.

Stability

W.R. Berkley Corporation reported net income of $1.8B in fiscal year 2025, against $1.8B in fiscal year 2024. Stability ranks insurers on how steady net income has been across five years, and W.R. Berkley Corporation scores 91/100 among other insurers.

Piotroski F-Score Partial

4/6

W.R. Berkley Corporation passes 4 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

2.01x

For every $1 of reported earnings, W.R. Berkley Corporation generates $2.01 in operating cash flow ($3.6B OCF vs $1.8B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.7B

YoY+1.2%

QoQ+0.7%

5Y CAGR+10.1%

10Y CAGR+7.2%

W.R. Berkley Corporation generated $3.7B in revenue in Q2 2026. This represents an increase of 1.2% from the same quarter a year earlier. Against the prior quarter it is up 0.7%.

Net Income

$452.3M

YoY+12.7%

QoQ-12.2%

5Y CAGR+13.8%

10Y CAGR+15.3%

W.R. Berkley Corporation reported $452.3M in net income in Q2 2026. This represents an increase of 12.7% from the same quarter a year earlier. Against the prior quarter it is down 12.2%.

EPS (Diluted)

$1.15

YoY+15.0%

QoQ-12.2%

5Y CAGR+6.2%

10Y CAGR+3.1%

W.R. Berkley Corporation earned $1.15 per diluted share (EPS) in Q2 2026. This represents an increase of 15.0% from the same quarter a year earlier. Against the prior quarter it is down 12.2%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt

$2.6B

YoY+31.3%

QoQ+14.3%

5Y CAGR+7.8%

10Y CAGR+10.6%

W.R. Berkley Corporation held $2.6B in cash as of Q2 2026; long-term debt is not reported for that period.

Dividends Per Share

$0.60

YoY+1.7%

QoQ+566.7%

5Y CAGR+7.4%

W.R. Berkley Corporation paid $0.60 per share in dividends in Q2 2026. This represents an increase of 1.7% from the same quarter a year earlier. Against the prior quarter it is up 566.7%.

Shares Outstanding

371M

YoY-2.1%

QoQ-0.3%

5Y CAGR+15.9%

10Y CAGR+11.7%

W.R. Berkley Corporation had 371M shares outstanding in Q2 2026. This represents a decrease of 2.1% from the same quarter a year earlier. Against the prior quarter it is down 0.3%.

Free Cash Flow

Not reported for Q2 2026.

Margins & Returns

Net Margin

12.2%

YoY+1.2pp

QoQ-1.8pp

5Y change+1.8pp

10Y change+6.3pp

W.R. Berkley Corporation's net profit margin was 12.2% in Q2 2026, showing the share of revenue converted to profit. This is up 1.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.8 percentage points.

Return on Equity

4.6%

YoY+0.3pp

QoQ-0.7pp

5Y change+1.0pp

10Y change+2.4pp

W.R. Berkley Corporation's ROE was 4.6% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.7 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

$111.5M

QoQ-63.1%

W.R. Berkley Corporation spent $111.5M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. Against the prior quarter it is down 63.1%.

R&D Spending

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

WRB Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

WRB quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$14.9B	$14.7B+7.8%	$13.6B+12.3%	$12.1B+8.7%	$11.2B+18.1%	$9.5B+16.7%	$8.1B+2.5%	$7.9B+2.7%	$7.7B+0.1%	$7.7B+0.4%	$7.7B+6.2%	$7.2B+1.1%	$7.1B+11.2%	$6.4B+10.0%	$5.8B+12.9%	$5.2B
Interest Expense	$126.8M	$126.9M0.0%	$126.9M-0.4%	$127.5M-2.2%	$130.4M-11.4%	$147.2M-2.2%	$150.5M-1.9%	$153.4M-2.4%	$157.2M+6.7%	$147.3M+4.5%	$140.9M+7.6%	$130.9M+2.2%	$128.2M+4.1%	$123.2M-2.5%	$126.3M+12.3%	$112.5M
Income Tax	$476.8M	$495.8M-2.8%	$509.9M+37.6%	$370.6M+10.7%	$334.7M+32.9%	$251.9M+46.6%	$171.8M+1.7%	$168.9M+3.6%	$163.0M-25.7%	$219.4M-25.1%	$293.0M+28.5%	$227.9M-24.7%	$302.6M+56.3%	$193.6M+1.2%	$191.3M+56.9%	$121.9M
Net Income	$1.9B	$1.8B+1.3%	$1.8B+27.2%	$1.4B0.0%	$1.4B+35.1%	$1.0B+92.6%	$530.7M-22.2%	$681.9M+6.4%	$640.7M+16.7%	$549.1M-8.8%	$601.9M+19.5%	$503.7M-22.4%	$648.9M+29.8%	$499.9M-2.1%	$510.6M+30.5%	$391.2M
EPS (Basic)	N/A	$4.48+2.1%	$4.39+29.1%	$3.40+2.1%	$3.33-9.8%	$3.69+95.2%	$1.89-47.2%	$3.58+6.2%	$3.37+15.0%	$2.93-40.3%	$4.91+20.9%	$4.06-19.9%	$5.07+37.4%	$3.69-0.8%	$3.72+32.9%	$2.80
EPS (Diluted)	$4.87	$4.45+2.1%	$4.36+29.4%	$3.37+2.4%	$3.29	$3.66+95.7%	$1.87-46.9%	$3.52+5.7%	$3.33+17.3%	$2.84	$4.68+20.9%	$3.87-20.4%	$4.86+36.9%	$3.55-0.3%	$3.56+32.3%	$2.69
Diluted Shares (Avg)	N/A	400M-0.8%	403M-1.6%	410M+97694.8%	419,192	279,749-1.2%	283,145+46.3%	193,521+0.6%	192,395-0.6%	193,527	129M-1.3%	130M-2.6%	134M-5.0%	141M-1.8%	143M-1.6%	146M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$3.7B+1.2%	$3.7B+4.0%	$3.7B+1.5%	$3.8B+10.8%	$3.7B+10.8%	$3.5B+8.9%	$3.7B+13.9%	$3.4B+12.2%
Interest Expense	$31.7M-0.2%	$31.7M-0.1%	$31.6M-0.4%	$31.8M+0.1%	$31.8M+0.2%	$31.7M0.0%	$31.8M-0.4%	$31.7M-0.5%
Income Tax	$122.9M+1.4%	$100.5M-17.1%	$117.2M-23.4%	$136.1M+24.7%	$121.2M+4.6%	$121.3M-8.2%	$153.0M+49.6%	$109.1M+26.1%
Net Income	$452.3M+12.7%	$515.2M+23.4%	$449.1M-22.0%	$511.0M+39.8%	$401.3M+7.9%	$417.6M-5.6%	$576.0M+45.1%	$365.6M+9.6%
EPS (Basic)	$1.16+14.9%	$1.31+24.8%	$1.13-21.5%	$1.29+40.2%	$1.01+8.6%	$1.05-4.5%	$1.44-2.7%	$0.92+10.8%
EPS (Diluted)	$1.15+15.0%	$1.31+26.0%	$1.13-21.5%	$1.28+40.7%	$1.00+8.7%	$1.04-4.6%	$1.44-1.4%	$0.91+11.0%
Diluted Shares (Avg)	392M-2.1%	395M-1.3%	N/A	400M-0.4%	400M-0.8%	400M-1.5%	N/A	402M-1.3%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA.

WRB Balance Sheet

WRB quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$43.9B+8.3%	$40.6B+9.0%	$37.2B+9.9%	$33.9B+5.5%	$32.1B+12.2%	$28.6B+7.3%	$26.7B+7.1%	$24.9B+2.5%	$24.3B+4.0%	$23.4B+7.5%	$21.7B+0.1%	$21.7B+5.7%	$20.6B+2.0%	$20.2B+9.5%	$18.4B
Cash & Equivalents	$2.5B+28.6%	$2.0B+44.9%	$1.4B-5.9%	$1.4B-7.6%	$1.6B-33.9%	$2.4B+131.7%	$1.0B+25.2%	$817.6M-14.0%	$950.5M+19.5%	$795.3M+4.1%	$763.6M+13.2%	$674.4M-19.7%	$839.7M0.0%	$839.7M-7.9%	$911.7M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$184.3M0.0%	$184.3M+5.6%	$174.6M-5.9%	$185.5M+9.3%	$169.7M0.0%	$169.7M0.0%	$169.7M-2.0%	$173.0M-3.3%	$178.9M+23.8%	$144.5M-5.7%	$153.3M+1.6%	$150.9M+37.0%	$110.1M+25.4%	$87.9M0.0%	$87.9M
Total Liabilities	$34.2B+6.4%	$32.2B+8.2%	$29.7B+9.7%	$27.1B+6.6%	$25.4B+14.1%	$22.3B+8.5%	$20.5B+5.8%	$19.4B+3.0%	$18.8B+3.1%	$18.3B+6.9%	$17.1B0.0%	$17.1B+5.6%	$16.2B+2.3%	$15.8B+9.5%	$14.4B
Total Equity	$9.7B+15.6%	$8.4B+12.6%	$7.5B+10.5%	$6.7B+1.4%	$6.7B+5.4%	$6.3B+3.9%	$6.1B+11.7%	$5.4B+0.5%	$5.4B+7.2%	$5.0B+9.7%	$4.6B+0.2%	$4.6B+5.9%	$4.3B+0.7%	$4.3B+8.9%	$4.0B
Retained Earnings	$13.3B+8.8%	$12.3B+11.1%	$11.0B+8.7%	$10.2B+12.7%	$9.0B+8.0%	$8.3B+5.2%	$7.9B+4.9%	$7.6B+8.6%	$7.0B+5.5%	$6.6B+6.8%	$6.2B+7.8%	$5.7B+8.9%	$5.3B+9.3%	$4.8B+7.3%	$4.5B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$45.7B+7.1%	$44.3B+7.2%	$43.9B+8.3%	$43.7B+8.3%	$42.7B+9.6%	$41.3B+9.2%	$40.6B+9.0%	$40.4B+11.8%
Cash & Equivalents	$2.6B+31.3%	$2.3B+32.6%	$2.5B+28.6%	$2.4B+52.8%	$2.0B+25.6%	$1.7B+47.1%	$2.0B+44.9%	$1.6B-4.4%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$184.3M0.0%	$184.3M0.0%	$184.3M0.0%	$184.3M+0.1%	$184.3M+0.1%	$184.3M+5.6%	$184.3M+5.6%	$184.1M+5.4%
Total Liabilities	$35.8B+7.4%	$34.6B+6.6%	$34.2B+6.4%	$33.9B+6.2%	$33.4B+7.2%	$32.4B+7.9%	$32.2B+8.2%	$31.9B+9.4%
Total Equity	$9.8B+5.8%	$9.7B+9.3%	$9.7B+15.6%	$9.8B+16.3%	$9.3B+19.6%	$8.9B+14.5%	$8.4B+12.6%	$8.4B+21.8%
Retained Earnings	$14.1B+9.6%	$13.8B+9.3%	$13.3B+8.8%	$13.3B+11.7%	$12.8B+9.9%	$12.7B+10.5%	$12.3B+11.1%	$11.9B+10.3%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

WRB Cash Flow Statement

WRB quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$3.6B	$3.6B-2.6%	$3.7B+25.6%	$2.9B+14.0%	$2.6B+17.6%	$2.2B+35.1%	$1.6B+41.3%	$1.1B+84.4%	$620.2M-12.8%	$710.9M-16.2%	$848.4M-3.7%	$881.3M+19.9%	$734.8M-10.4%	$819.8M+21.4%	$675.5M+0.8%	$670.3M
Depreciation & Amortization	N/A	-$48.1M+71.8%	-$170.6M-718.0%	-$20.9M-137.3%	$55.9M-56.9%	$129.7M-4.0%	$135.1M+19.1%	$113.4M-13.5%	$131.1M+16.1%	$113.0M+31.3%	$86.1M+1.1%	$85.1M-4.2%	$88.8M-13.8%	$103.1M-0.3%	$103.4M+17.5%	$88.0M
Stock-Based Compensation	N/A	$54.5M+0.3%	$54.4M+6.6%	$51.0M+3.2%	$49.4M+5.9%	$46.7M-6.0%	$49.7M+0.8%	$49.3M+34.7%	$36.6M-9.6%	$40.5M+8.9%	$37.2M+15.7%	$32.1M+14.4%	$28.1M+18.0%	$23.8M-11.1%	$26.8M-1.5%	$27.2M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$60.5M+21.3%	$49.9M-56.9%	$115.7M+127.7%	$50.8M-20.0%	$63.6M+51.5%	$42.0M-33.6%	$63.1M+55.7%	$40.6M-10.5%	$45.3M
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$1.1B+89.9%	$570.3M-4.2%	$595.2M-25.4%	$797.5M-2.5%	$817.7M+18.0%	$692.9M-8.4%	$756.6M+19.2%	$634.9M+1.6%	$625.0M
Investing Cash Flow	-$1.8B	-$2.0B+7.1%	-$2.2B-11.3%	-$2.0B-3.7%	-$1.9B+36.7%	-$3.0B-2597.3%	$119.7M+128.2%	-$424.9M+40.5%	-$714.2M-114.2%	-$333.5M+58.0%	-$794.5M-365.3%	-$170.8M+78.9%	-$808.3M-48.2%	-$545.4M+29.6%	-$775.1M-279.4%	-$204.3M
Financing Cash Flow	-$1.2B	-$1.0B-20.4%	-$852.5M+19.8%	-$1.1B-37.6%	-$772.0M-13339.4%	$5.8M+101.5%	-$397.8M+22.5%	-$513.2M-6832.2%	-$7.4M+96.9%	-$235.1M-3291.3%	-$6.9M+98.8%	-$555.3M-695.9%	-$69.8M+78.9%	-$330.3M-439.8%	$97.2M+149.8%	-$195.2M
Dividends Paid	$479.8M	$700.3M+31.6%	$532.0M+6.1%	$501.5M+113.2%	$235.2M-33.9%	$355.7M+322.8%	$84.1M-72.7%	$308.2M+20.9%	$255.0M+35.5%	$188.2M+2.3%	$184.0M+217.1%	$58.0M-68.0%	$181.5M+244.3%	$52.7M-71.3%	$183.9M+325.3%	$43.3M
Share Buybacks	$634.9M	$270.2M-11.0%	$303.7M-43.5%	$537.2M+470.6%	$94.1M-23.1%	$122.4M-64.7%	$346.4M+1800.4%	$18.2M-26.4%	$24.8M-48.2%	$47.8M-63.9%	$132.4M-40.8%	$223.7M-6.4%	$238.9M+43.5%	$166.5M+30.4%	$127.7M-31.8%	$187.2M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$800.0M+13.7%	$667.9M-10.2%	$995.1M+22.9%	$1.1B-8.1%	$703.8M-20.1%	$743.8M-0.3%	$810.0M+16.0%	$1.2B+15.2%
Depreciation & Amortization	-$22.1M-58.5%	-$15.5M-58.0%	-$15.3M-12.1%	-$9.1M+24.0%	-$14.0M+78.3%	-$9.8M+87.9%	-$13.6M+43.5%	-$11.9M-230.9%
Stock-Based Compensation	N/A	$13.2M+6.5%	N/A	N/A	N/A	$12.4M-4.3%	N/A	N/A
Investing Cash Flow	-$361.0M-54.1%	-$588.6M+36.3%	-$243.1M-179.2%	-$627.6M+43.2%	-$234.2M-168.6%	-$924.4M-2.1%	-$87.1M+84.6%	-$1.1B+10.5%
Financing Cash Flow	-$127.7M+44.9%	-$339.1M-316.5%	-$618.1M-112.7%	-$95.3M+38.1%	-$231.7M+38.8%	-$81.4M-174.1%	-$290.5M+31.4%	-$153.8M-573.3%
Dividends Paid	$0-100.0%	$33.7M+11.1%	$411.9M+86.9%	$34.2M-72.8%	$223.8M+42.1%	$30.3M+7.5%	$220.4M-29.9%	$125.8M
Share Buybacks	$111.5M	$302.4M+514.7%	$196.4M+191.3%	$24.6M+97.3%	$0-100.0%	$49.2M	$67.4M-36.8%	$12.5M+327.8%

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow.

WRB Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

WRB quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Net Margin	12.1%-0.8pp	12.9%+1.5pp	11.4%-1.0pp	12.4%+1.6pp	10.8%+4.3pp	6.6%-2.1pp	8.6%+0.3pp	8.3%+1.2pp	7.1%-0.7pp	7.9%+0.9pp	7.0%-2.1pp	9.1%+1.3pp	7.8%-1.0pp	8.8%+1.2pp	7.6%
Return on Equity	18.3%-2.6pp	20.9%+2.4pp	18.5%-1.9pp	20.5%+5.1pp	15.4%+6.9pp	8.4%-2.8pp	11.2%-0.6pp	11.8%+1.6pp	10.2%-1.8pp	11.9%+1.0pp	10.9%-3.2pp	14.1%+2.6pp	11.5%-0.3pp	11.9%+2.0pp	9.9%
Return on Assets	4.0%-0.3pp	4.3%+0.6pp	3.7%-0.4pp	4.1%+0.9pp	3.2%+1.3pp	1.9%-0.7pp	2.6%0.0pp	2.6%+0.3pp	2.3%-0.3pp	2.6%+0.3pp	2.3%-0.7pp	3.0%+0.6pp	2.4%-0.1pp	2.5%+0.4pp	2.1%
Debt-to-Equity	3.53-0.3x	3.83-0.2x	3.990.0x	4.01+0.2x	3.82+0.3x	3.53+0.1x	3.38-0.2x	3.57+0.1x	3.48-0.1x	3.62-0.1x	3.720.0x	3.720.0x	3.73+0.1x	3.670.0x	3.65
Asset Turnover	0.330.0x	0.340.0x	0.330.0x	0.330.0x	0.290.0x	0.280.0x	0.300.0x	0.310.0x	0.320.0x	0.330.0x	0.330.0x	0.330.0x	0.310.0x	0.290.0x	0.28
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	13.7%+6.3pp	7.4%-0.3pp	7.7%-2.7pp	10.4%-0.9pp	11.3%+1.6pp	9.7%-2.1pp	11.8%+0.9pp	10.9%-1.2pp	12.1%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Net Margin	12.2%+1.2pp	14.0%+2.2pp	12.1%-3.6pp	13.6%+2.8pp	10.9%-0.3pp	11.8%-1.8pp	15.7%+3.4pp	10.8%-0.3pp
Return on Equity	4.6%+0.3pp	5.3%+0.6pp	4.6%-2.2pp	5.2%+0.9pp	4.3%-0.5pp	4.7%-1.0pp	6.9%+1.5pp	4.3%-0.5pp
Return on Assets	1.0%+0.1pp	1.2%+0.1pp	1.0%-0.4pp	1.2%+0.3pp	0.9%0.0pp	1.0%-0.2pp	1.4%+0.4pp	0.9%0.0pp
Debt-to-Equity	3.64+0.1x	3.55-0.1x	3.53-0.3x	3.46-0.3x	3.59-0.4x	3.64-0.2x	3.83-0.2x	3.79-0.4x
Asset Turnover	0.080.0x	0.080.0x	0.080.0x	0.090.0x	0.090.0x	0.090.0x	0.090.0x	0.080.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
W.R. Berkley Corporation WRB	FY2025	$14.7B	$1.8B	12.1%	$25.6B	52/100
Markel Group Inc. MKL	FY2025	$15.5B	$2.1B	13.6%	$21.5B	24/100
Cincinnati Financial Corp CINF	FY2025	$12.6B	$2.4B	18.9%	$24.9B	40/100
The Hartford Insurance Group, Inc. HIG	FY2025	$28.4B	$3.8B	13.5%	$34.1B	36/100
Loews Corporation L	FY2025	$18.5B	$1.7B	9.0%	$21.7B	27/100
The Allstate Corporation ALL	FY2025	$67.7B	$10.2B	15.0%	$56.6B	23/100

Where W.R. Berkley Corporation Ranks

Frequently Asked Questions

What is W.R. Berkley Corporation's annual revenue?

W.R. Berkley Corporation (WRB) reported $14.7B in total revenue for fiscal year 2025. This represents a 7.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is W.R. Berkley Corporation's revenue growing?

W.R. Berkley Corporation (WRB) revenue grew by 7.8% year-over-year, from $13.6B to $14.7B in fiscal year 2025.

Is W.R. Berkley Corporation profitable?

Yes, W.R. Berkley Corporation (WRB) reported a net income of $1.8B in fiscal year 2025, with a net profit margin of 12.1%.

What is W.R. Berkley Corporation's net profit margin?

W.R. Berkley Corporation (WRB) had a net profit margin of 12.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does W.R. Berkley Corporation pay dividends?

Yes, W.R. Berkley Corporation (WRB) paid $1.85 per share in dividends during fiscal year 2025.

What is W.R. Berkley Corporation's return on equity (ROE)?

W.R. Berkley Corporation (WRB) has a return on equity of 18.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is W.R. Berkley Corporation's operating cash flow?

W.R. Berkley Corporation (WRB) generated $3.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are W.R. Berkley Corporation's total assets?

W.R. Berkley Corporation (WRB) had $43.9B in total assets as of fiscal year 2025, including both current and long-term assets.

Does W.R. Berkley Corporation buy back shares?

Yes, W.R. Berkley Corporation (WRB) spent $270.2M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does W.R. Berkley Corporation have outstanding?

W.R. Berkley Corporation (WRB) had 374M shares outstanding as of fiscal year 2025.

What is W.R. Berkley Corporation's debt-to-equity ratio?

W.R. Berkley Corporation (WRB) had a debt-to-equity ratio of 3.53 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is W.R. Berkley Corporation's return on assets (ROA)?

W.R. Berkley Corporation (WRB) had a return on assets of 4.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is W.R. Berkley Corporation's P/E ratio?

W.R. Berkley Corporation (WRB) trades at 13.3x earnings, its market capitalization divided by net income of $1.9B net income, trailing 12 months to June 30, 2026. The market capitalization is $25.6B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is W.R. Berkley Corporation's price-to-sales ratio?

W.R. Berkley Corporation (WRB) trades at 1.7x sales, its market capitalization divided by revenue of $14.9B revenue, trailing 12 months to June 30, 2026. The market capitalization is $25.6B as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is W.R. Berkley Corporation's Piotroski F-Score?

W.R. Berkley Corporation (WRB) has a Piotroski F-Score of 4 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are W.R. Berkley Corporation's earnings high quality?

W.R. Berkley Corporation (WRB) has an earnings quality ratio of 2.01x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is W.R. Berkley Corporation?

W.R. Berkley Corporation (WRB) scores 52 out of 100 on our Financial Health Score, indicating moderate standing within its insurers peer group. The score is a 0-100 composite of six dimensions (Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.